Cargando…
Allogenic Amniotic Tissue for Treatment of Knee and Hip Osteoarthritis
Osteoarthritis (OA) impacts millions of people and places a high burden on healthcare systems in the United States. Current treatment modalities have limitations and do not address underlying pathology. Lately, there has been an immense growth in the use of biologics, including perinatal allogenic t...
Autor principal: | Gupta, Ashim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9031613/ https://www.ncbi.nlm.nih.gov/pubmed/35455401 http://dx.doi.org/10.3390/ph15040404 |
Ejemplares similares
-
Allogenic platelet-rich plasma for treatment of knee and hip osteoarthritis
por: Gupta, Ashim, et al.
Publicado: (2023) -
Amniotic Suspension Allograft for Treatment of Knee Osteoarthritis
por: Gupta, Ashim
Publicado: (2022) -
Allogenic Umbilical Cord Tissue as a Scaffold for Ankle Osteoarthritis
por: Gupta, Ashim, et al.
Publicado: (2023) -
Autologous Adipose Tissue vs. Platelet-Rich Plasma for Treatment of Knee Osteoarthritis
por: Gupta, Ashim
Publicado: (2022) -
StemOne(TM)/Stempeucel(®): CDSCO Approved, Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogenic Mesenchymal Stem Cells for Knee Osteoarthritis
por: Gupta, Ashim
Publicado: (2023)